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ABSTRACT
Low measles, mumps and rubella (MMR) immunization levels in European children highlight the
importance of identifying determinants of parental vaccine uptake to implement policies for increasing
vaccine compliance. The aim of this paper is to identify the main factors associated with partial and full
MMR vaccination uptake in European parents, and combine the different studies to obtain overall
quantitative measures. This activity is included within the ESCULAPIO project, funded by the Italian
Ministry of Health. ORs and CIs were extracted, sources of heterogeneity explored and publication bias
assessed. Forty-ﬁve papers were retrieved for the qualitative study, 26 of which were included in the meta-
analysis. The following factors were associated with lower MMR vaccine uptake: misleading knowledge,
beliefs and perceptions on vaccines (OR 0.57, CI 0.37-0.87); negative attitudes and behaviors toward
vaccination (OR 0.71, CI 0.52-0.98); demographic characteristics, such as different ethnicity in Southern
populations (OR 0.44, CI 0.31-0.61), higher child’s age (OR 0.80, CI 0.76-0.85); low socio-economic status
(OR 0.64, CI 0.51-0.80), especially low income (OR 0.39, CI 0.25-0.60) and education (OR 0.64, CI 0.48-0.84),
high number of children (OR 0.54, CI 0.42-0.69), irregular marital status (OR 0.80, CI 0.66-0.96). The factors
explaining heterogeneity were country location, administration modality, collection setting and responses
reported on MMR alone or in combination. Findings from this study suggest policy makers to focus
communication strategies on providing better knowledge, correct beliefs and perceptions on vaccines,
and improving attitudes and behaviors in parents; and to target policies to people of ethnic minority from
Southern Europe, low educated and deprived, with higher number of children and non-married marital
status.
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Introduction
Measles, mumps and rubella (MMR) are serious diseases that
can cause signiﬁcant morbidity and lead to potentially fatal ill-
ness, disability and death.1 Despite the introduction of the tri-
valent MMR vaccine in the 1970s, measles is still circulating in
several regions of Europe, mainly in the form of recurring spa-
tially localized epidemics, with 4,284 cases reported during the
recent 12-month period (June 2014 – May 2015) in 30 EU/EEA
Member States,2 77% of which in unvaccinated subjects, and
15.5% in vaccinated with 1 dose. The low immunization levels
found in Europe highlight the importance of identifying and
understanding the factors that affect the uptake of recom-
mended childhood immunizations,3 to address proper inter-
ventions and implement public health policies aimed at
increasing vaccine compliance. Uptake could be improved by
understanding and modifying the complex structures that are
behind vaccination decisions.4 Different studies have been car-
ried out to elicit parental concerns about MMR vaccinations.
Recent reviews analyzed factors underlying parental deci-
sions,4,5 demonstrating that vaccine-acceptors and vaccine-
decliners do think differently on a number of factors, such as
effectiveness or safety of the vaccine, trust in health professio-
nals, media and government, need of better information.
Although many qualitative reviews exist in the literature, to
our knowledge there is a lack of meta-analyses that could inves-
tigate parental MMR vaccine predictors by systematically com-
bining results from different studies. The present paper aimed
at identifying the main factors associated with partial and full
MMR vaccination uptake in European parents, and performing
a meta-analysis of the main classes of factors predicting paren-
tal MMR vaccine catch-up. This activity was included within
the ESCULAPIO project, funded by the Italian National Centre
for Disease Prevention and Control of the Ministry of Health
(CCM), with the main objective of implementing targeted cam-
paigns and planning effective strategies to increase vaccine
coverage.
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Results
An initial number of 452 articles was retrieved; no. 434 records
were obtained after excluding duplicates, and through the ini-
tial screening of titles and abstracts no. 108 full text articles
were assessed for eligibility (Fig. 1). A total of 45 studies met all
the inclusion criteria and were then included in the qualitative
synthesis (Table 1);3,6-49 out of the 32 quantitative studies
retrieved, no. 26 reported ORs and CIs and then were included
in the meta-analysis.3,6,7,9-11,14-17,19,21,23-27,29,31,33,34,37,38,40,42,48
The characteristics of the retrieved studies are reported in
Table 2, and Fig. 2 shows the frequency of factors reported in
the retrieved articles.
Quantitative analysis
Knowledge, beliefs, perceptions on vaccines and diseases
(KBPvd)
Nine studies reported 22 population samples having both good
and misleading KBPvd.3,14-16,24,34,37,38,40 The analysis showed
no clear effect for the overall population of parents. Since high
heterogeneity was present between the studies, a random effect
model was used for the subgroup analysis. After eliminating
the outliers, i.e. 1 sample from Brown et al.,16 2 populations
from Hak et al.38 1 from Paulussen et al.,34 and 1 from
Sch€onberger et al.,15 and performing the subgroup analysis, a
clear and signiﬁcant effect was revealed for the group of the
KBPv (OR 0.57, CI 0.37 to 0.87) compared to the group on dis-
eases, which tended, instead, to have better knowledge, beliefs,
perceptions and then to be more likely to vaccinate (OR 1.62,
CI 1.32–1.99) (Fig. 3). In this last group a low between study
heterogeneity was revealed (I2 38.5% p D 0.181). Lower KBPvd
were also observed for parents ﬁlling self-administered ques-
tionnaires (OR 0.34, CI 0.13–0.86) and parents from Western
countries (OR 0.60, CI 0.38–0.93).
Attitudes/behaviors
Positive or negative attitudes/behaviors toward vaccinations
were reported in 11 studies showing 20 population sam-
ples.6,17,23,25-27,31,33,34,40,48 After eliminating outliers,34,40 overall
negative attitudes and behaviors toward vaccination were found
out, that took to decreasing vaccination choices (ﬁxed effect OR
0.79, CI 0.73–0.86; random effect OR 0.71, CI 0.52–0.98). The
effect was due to interviewer-administered (IW) questionnaires
Figure 1. Flow diagram of the systematic literature review process on the determinants of European parents’ decision of vaccinating their children against measles,
mumps and rubella.
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(OR 0.61, CI 0.40–0.94), in particular IW face-to-face (OR 0.54,
CI 0.35–0.83), and Western European countries (OR 0.40, CI
0.25–0.66).
Demographics
Ethnicity, child’s age, and gender were the demographic
considered factors
With regard to ethnicity, the overall effect was a slightly
decreased likelihood of vaccinating their children from parents
of ethnic minorities than the majority in the ﬁxed effect model
(OR 0.89, CI 0.86–0.93), but this effect disappeared in the ran-
dom effect (OR 1.03, CI 0.79–1.34). In Northern countries, a
higher vaccination uptake was revealed (OR 1.74, CI 1.25–
2.42), compared to the parents from Southern countries (OR
0.44, CI 0.31–0.61), while in Western European parents there
was no signiﬁcant effect (Fig. 4).
When analyzing responses to MMR vaccine and MMR plus
other vaccines in local schedules, parents who provided non-
speciﬁc responses were less prone to vaccinate and the hetero-
geneity was lower (OR 0.42, CI 0.30 to 0.58; I2 66.7%
p D 0.006) compared to those who provided speciﬁc answers
on MMR vaccine (OR 1.26, CI 1.07–1.44).
Child’s age was in the direction that the higher the age the
lower the vaccination uptake (OR 0.80, CI 0.76–0.85 both ﬁxed
and random). Female gender tended to be vaccinated less (OR
0.57, CI 0.56–0.58 ﬁxed effect); in the random effect model no
signiﬁcant effect was observed.
Socio-economic status (SES)
Twenty-four samples of parents from 9 papers3,7,11,21,23,25-27,38
reported an association between vaccine uptake and SES. The
overall effect indicated that the lower the SES, the lower the
vaccination uptake both in the ﬁxed and random effect models
(OR 0.82, CI 0.77–0.87 and OR 0.64, CI 0.51–0.80,
respectively).
Income and education level were the responsible of the
observed effect, with less than double and a half likelihood of
vaccinating for parents with lower incomes (OR 0.39, CI 0.25–
0.60) and lower likelihood for parents with lower education
level (OR 0.64, CI 0.48–0.84) (Fig. 5). A stronger effect, more-
over, was showed for Western European countries (OR 0.33, CI
0.24–0.45), which showed also homogeneity between studies
(I2 0.0%, p D 0.889).
Employment and house tenure did not show signiﬁcant
effect. With regard to the income, studies were homogeneous
for the home setting, IW face-to-face (I2 0.0% p D 0.890) and
Western Europe (I2 0.0% p D 0.730). The non-married status
(i.e., single, divorced, co-habiting, homosexual partnership)
was a barrier to vaccination (OR 0.80, CI 0.66–0.96; I2 64,6%
p D 0.059 random effect model). The higher was the no. of chil-
dren in the household, the lower was the uptake (ﬁxed effect OR
0.70, CI 0.66–0.75; random effect OR 0.54, CI 0.42–0.69).
Information source/advice
Eleven population samples from 6 studies reported ORs and
CIs of information sources/advice.7,15,17,37,42,48 The information
source is often lacking or insufﬁcient, as well as the advice from
GP or other health practitioners, this leading to an overall lower
vaccination uptake (OR 0.75, CI 0.67–0.84 ﬁxed effect model);
in the random effect model no clear effect was showed.
In the subgroup analysis, the administration method
revealed opposite directions: parents answers to IW by tele-
phone demonstrated a less likelihood of vaccinating (OR 0.53,
CI 0.43–0.64), and studies were moderately heterogeneous (I2
54,7% p D 0.085); parents responding to an IW by face-to-face
were 3 times more prone to vaccinate (OR 3.12, CI 2.24–4.34)
and studies were quite homogeneous (I2 30.9%, p D 0.227);
self-administered (SA) postal had not a clear direction (Fig. 6).
Inﬂuence or trust of other people, institutions, media
Four articles with 6 population samples16,38,43 reported that
natural practitioners/naturopaths did not inﬂuence decisions of
parents to vaccinate their children, and they had faith in media
and in the medical profession, so that the total effect was a gen-
eral positive inﬂuence from other people or institutions and
media, in the ﬁxed effect model (OR 1.94, CI 1.53–2.46), while
the random effect model did not show a clear direction. The
Table 2. Characteristics of the retrieved 45 articles on the determinants of Euro-
pean parental decision of vaccinating their children against measles, mumps and
rubella (MMR).
Study characteristics No. %
Data collection method
 Questionnaires 28 62
 Interviews 12 27
 Focus groupsa 5 11
 Ofﬁcial records 3 7
Administration modalityb
 Interviewer-administered 23 51
 Self-administered 18 40
Data collection setting
 Home 29 64
 Hospital/nursery/primary care trust 6 13
 Day-care centers/Schools 4 9
 Otherc 3 7
Geographical location
 Northern Europed 22 49
 Western Europee 14 31
 Southern Europef 9 20
Questionnaires reporting on
 MMR vaccine alone 31 69
 MMR plus other vaccines included in the local schedule 14 31
MMR vaccine schedule adherence
 All recommended doses 15 33
 1 dose 8 18
 Both 6 13
Children’s age at the moment of the study
  5 y 30 67
 > 5 y 3 7
 Mixed age 9 20
ausing semi-structured protocol with open-ended questions, questionnaires or
interviews, or discussions, recorded and transcribed
bdelivered by post, by telephone or by hand, or face-to-face interviews
canthroposophical child welfare centers, community halls, shopping centers and
parks
d19 studies in UK, 2 in Sweden, 1 in Ireland
e6 studies in Belgium, 5 in The Netherlands, 2 in Germany, 1 in France
f4 studies in Greece, 3 in Spain, 2 in Italy
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subgroup analysis did not reveal any particular effect, also
because of the low number of the studies.
Discussion
This review and meta-analysis summarize evidence on the fac-
tors underlying parental decisions about single and combined
MMR vaccines uptake for their children in Europe.
To our knowledge, this is the ﬁrst meta-analysis study
regarding the MMR vaccination uptake in European popula-
tions of parents. Although this poses some limits to the possi-
bility of comparing our results with data from other authors, it
provides new insights in the overall parental decision on vacci-
nating their children from a quantitative point of view.
The qualitative analysis showed that most parents are
not totally directed to one clear attitude toward
Figure 2. Determinants of European parents’ decision on the vaccination of their children against measles, mumps and rubella, reported in the retrieved 45 articles.
Table 3. Analysis for funnel plot asymmetry of studies reporting the different variables, estimated by Egger’s regression test.
No. studies coefﬁcient 90% CI p-value
Knowledge, beliefs, perceptions (right vs misleading) 19 ¡2.21 ¡5.560 – 1.178 0.272
Attitudes/behaviors (positive vs negative) 18 ¡0.83 ¡3.508 – 1.843 0.595
Ethnicity (different vs local) 31 3.24 0.339 – 6.138 0.068
Socio-economic status (high vs low) 24 2.55 0.825 – 4.268 0.019
Information source/advice (sufﬁcient vs insufﬁcient) 11 6.64 2.140 – 11.137 0.024
1916 G. TABACCHI ET AL.
Figure 3. Forest plot of the overall effect (showed as exponentiated Odds Ratios and Conﬁdence Intervals) of parental knowledge, beliefs and perceptions (KBP) on mea-
sles, mumps and rubella vaccine uptake, examined by KBP on vaccines and on diseases.
Figure 4. Forest plot of the overall effect (showed as exponentiated Odds Ratios and Conﬁdence Intervals) of parental ethnic minority on measles, mumps and rubella
vaccine uptake, examined by study geographical location.
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vaccination, and this, in line with Brown et al.,4 highlights
the multifaceted nature of their choice. However, robust
indications emerge from the quantitative analysis, evidenc-
ing speciﬁc variables underlying parental decision to vacci-
nate their children.
Results from the meta-analysis revealed opposite effects for
overall KBPv compared to those regarding diseases. The ﬁrst
were misleading and drove parents to a lower vaccination
uptake, while the second appeared more positive and correct;
this could be related to the very wide claim that because some
Figure 5. Forest plot of the overall effect (showed as exponentiated Odds Ratios and Conﬁdence Intervals) of parental socio-economic status on measles, mumps and
rubella vaccine uptake, examined by speciﬁc socio-economic determinants.
Figure 6. Forest plot of the overall effect (showed as exponentiated Odds Ratios and Conﬁdence Intervals) of parental information source/advice opinions on measles,
mumps and rubella vaccine uptake, examined by administration modality.
1918 G. TABACCHI ET AL.
diseases are becoming less prevalent, people’s perceptions and
knowledge about their dangers are being altered, and hence
their vaccine uptake rates are affected. These results are par-
tially in line with reviews stating that public debate over the
MMR vaccine safety in several countries persists, and this
underpins most hesitant attitudes.1,50
Some characteristics emerged negatively associated with
parents’ choices, such as the KBPvd reported in SA question-
naires or referred to Western European countries.
Similar considerations have to be done also for the attitudes
and behaviors, which were frequently reported uptake determi-
nants. When investigating the overall population, negative atti-
tudes and behaviors were prevalent, decreasing to the half the
vaccination uptake of parents. From the subgroup analysis, the
same negative effect was found in IW face-to-face question-
naires and Western countries. Attitudes and behaviors are often
likely consequences of misleading information; thus our results
suggest, in line with other studies,4,50 that interventions should
be focused on better communication strategies that could pro-
vide parents with clear messages speciﬁcally on vaccines, in
order to build right KBP and create correct attitudes and behav-
iors. These messages should be addressed mainly to vaccine
efﬁcacy, safety, bad side effects/consequences, health protec-
tion, necessity; and focusing on the importance of the compli-
ance with the second dose of the MMR vaccine. Still some
concern exists with regard to the link between vaccine and
autism, thus messages to parents should clearly expose the last
scientiﬁc literature denial on such a link and the possible mech-
anisms underlying the real upset of the autism.51
Demographics are important and frequently reported fac-
tors inﬂuencing parental choices, and the quantitative speciﬁc
results on the ethnicity suggest that communication strategies
should be targeted on parents of ethnic minority, living particu-
larly in Southern countries of Europe. This result is difﬁcult to
explain; probably people of minor ethnicity in UK (the only
Northern country represented in the articles about demo-
graphics) are more integrated and then more informed about
vaccination beneﬁts.
Our analysis suggests that communication strategies should
be addressed also to lower SES families, in particular to those
families with low income and low education level. Parents hav-
ing high incomes have more than twice likelihood of vaccinat-
ing their kids, and those with high education levels have one
and a half likelihood. Higher education is a determinant for
positive vaccination uptake particularly for partial vaccine
adherence, home environment, IW questionnaires/interviews
and non-speciﬁc MMR vaccine intentions. Parents coming
from Western countries are 3 times more prone to vaccinate,
with homogeneity conﬁrming the consistency of the studies.
Moreover, having a numerous family and a non-married status
are barriers for vaccination, this suggesting that interventions
should be targeted to these types of families. These results are
in line with other studies.4,31,52
An overall lack of information source or advice is revealed in
the quantitative analysis when using a ﬁxed effect model, taking
parents to a general decision of non-vaccinating their own chil-
dren, but this is not conﬁrmed in the random effect models.
Both the literature and market research data conﬁrmed that
advice from healthcare professionals is the main and most
inﬂuential source of vaccination information for most peo-
ple.5,50 Even though professionals report difﬁculties in building
trustful relationships with patients,50 in our meta-analysis
parents complain about the physician or GP not giving advice
for vaccination. They also criticize scarce television and news-
papers information. This suggests that GP and the other health
practitioners should be adequately informed in order to better
transfer knowledge to parents. Full information packs about
vaccinations should be distributed, and mass media informa-
tion should be fortiﬁed. On the other hand, when answers are
provided via face-to-face interviews and within an environment
different from home, the overall effect is opposite, with parents
more disposed to vaccinate their children of 3 times and 2 and
a half times respectively. It may be hypothesized that the pres-
ence of an interviewer and an environment different from own
home could take parents to answer positively toward vaccina-
tion choices, even though this cannot be veriﬁed.
The concept of information trust and advice is linked with
the inﬂuence exercised by other people, institutions and media.
Even though the analysis through the ﬁxed effect model
revealed an overall positive inﬂuence of other people, institu-
tions and media, and an overall lacking or insufﬁcient informa-
tion source and advice from GP or other health practitioners, a
robust effect could not be demonstrated when using the ran-
dom effect model.
Among the considered variables, the quality of the articles
was fair or good, this showing that studies were reliable, and no
evidence was showed that the ﬁndings differed systematically
for fair or good quality studies. Similarly, vaccine schedule
adherence, children’s age at the moment of the study and data
collection method (interview, questionnaire, ofﬁcial database)
did not inﬂuence the results of the meta-analysis. The following
factors, instead, were found mostly explaining the heterogeneity
between studies: speciﬁcity of the response on vaccines, country
location, administration modality, and setting.
As showed by the UNICEF and WHO,53 evidence suggests
that uptake varies by vaccine, therefore parents may not make
decisions about the entire vaccine schedule, but rather about
individual vaccines. Our meta-analysis conﬁrms that in some
cases parents make different decisions with regard to responses
on MMR vaccine alone or MMR plus other vaccines included
in the local schedule. E.g. parents of ethnic minority are dis-
posed to vaccinate for MMR diseases and are not for other vac-
cines included in a schedule; conversely, parents with high
education levels look like more inclined to vaccinate when they
answer on the combination vaccines rather than on the speciﬁc
MMR one. Anyway, a common consistent direction was not
revealed through our meta-analysis when parental responses
were about combination vaccines rather than speciﬁc MMR
vaccine; this is not in line with results from Brown et al 4, who
stated that there were consistent and signiﬁcant relationships
between negative perceptions of combination vaccines (e.g.
belief in safety/preferability of separate vaccines and fear of
immune overload) and lower vaccine uptake, and qualitative
evidence that these issues were more inﬂuential in MMR deci-
sions than in decisions about other combination vaccines.
With regard to country location, parents fromWestern areas
have generally misleading KBPv and more negative attitudes/
behaviors, and then are less prone to vaccinate their children,
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compared to parents from Northern countries, that are more
prone to vaccinate. The IW administration modality is mostly
negatively inﬂuencing vaccine uptake, even though in some
cases also positive inﬂuence is showed, as well as home
environment.
Limitations
Different limitations can be found in the present study
The symmetry of the funnel plots was examined to search for
possible publication bias or even heterogeneity. Asymmetry
was found for studies reporting ethnicity, SES and information
source/advice (Table 3).
The ethnicity and SES were also analyzed through a contour
plot where the missing studies were in a bottom left and bottom
right area of signiﬁcance, so publication bias was unlikely to be
the underlying cause of asymmetry; in the information source/
advice contour plot, instead, missing studies were in the area of
not signiﬁcance, thus a publication bias may be hypothesized
on missing studies (supplemental ﬁle S1). Since studies are
missing on the actual parents’ opinions on information source
and advices about vaccinations and related diseases, this could
be a factor to be considered in the strategies to plan to increase
vaccine compliance. Immunization guidance for health profes-
sionals could focus more on improving parents’ satisfaction
with vaccination consultations, and fostering trusting relation-
ships with parents in the context of immunization.4,52
This study suffers from a limitation due to the arbitrary clas-
siﬁcation of the analyzed factors.
The authors have decided to combine and analyze some var-
iables that can be incorporated into 1 main class of determi-
nants (e.g., the main “knowledge, beliefs and perceptions” class
includes parents’ responses on these 3 aspects), this leading to
decrease the methodological rigour of the meta-analysis. More-
over, there is often confusion between terms such as attitudes,
perceptions or beliefs, also due to the lack of a standard tool for
assessment of immunization decision-making. Nevertheless,
the authors were supported by the idea that for the develop-
ment of effective health communication campaigns it is impor-
tant to recognize underlying beliefs. Theoretical models use
these classes of determinants54 that lead to change people’s
intentions and engage them in health behaviors.
A different coding of the variables underlying parental deci-
sion was also present in the analyzed studies, that may have led
to under evaluate some less reported determinant, and then to
an incomplete framework of the situation.
All this suggests the need of developing a standardized tool
to better investigate the decision-making process across parents
and other populations as well, and to compare studies at the
international level.
A potential overestimation of the actual uptake could have
occurred, since examined studies generally used subjective
measures of vaccine uptake that cause recall bias,55 so that e.g.
past attitudes/behaviors can be confused with the current ones.
Objective data from primary care records are needed, to pro-
duce a more reliable measure of uptake.4 In our meta-analysis,
data from ofﬁcial databases were reported only for what con-
cerns demographics, and, as previously mentioned, no
difference was noticed in the subgroup analysis with the ques-
tionnaires or interviews.
A possible limit of the present study could also be the differ-
ent vaccine policy and strategy of the European countries, and
the different vaccine introduction time within each country, all
factors that could have inﬂuenced parents in their vaccination
choices. Finally, data in this analysis were available only for
some European countries (e.g., publications from the Eastern
area were missing).
Conclusions and policy implications
Overall misleading knowledge, beliefs and perceptions on vac-
cines, general negative attitudes and behaviors toward vaccina-
tion, some demographic characteristics such as minor
ethnicity, low socio-economic status (especially low income
and education, high number of children and non-married sta-
tus) are strong predictors of lower MMR vaccination uptake in
European parents for their children. These ﬁndings could be
used to suggest that policies aimed at increasing MMR vaccine
uptake in Europe should be focused on providing better knowl-
edge, creating correct beliefs and perceptions on vaccines,
improving attitudes and behaviors in European parents. Thus,
interventions should be focused on better communication
strategies that could provide parents with clear messages specif-
ically on vaccine efﬁcacy, safety, bad side effects/consequences,
health protection, necessity, and that could highlight the
importance of the compliance with the second dose of the
MMR vaccine. Moreover, communication strategies should be
addressed mainly to people of ethnic minorities living in South-
ern Europe, and to low educated and deprived families, with
higher number of children and non-married marital status.
Health practitioners on their side could be adequately informed
in order to better transfer knowledge to parents.
This paper could suggest carrying on similar studies in East-
ern European countries, to obtain a complete framework of the
European situation about the determinants of the decision of
parents of vaccinating their children against MMR.
Material and methods
Systematic literature review
A systematic literature review (SLR) was carried out on the fac-
tors associated with MMR vaccine uptake by parents, consider-
ing key terms used in combination and referred to vaccine/
immunization, uptake/coverage, determinant/factor, and mea-
sles, mumps and rubella, with medical Subject Headings
(MeSH) and MeSH Major Topics included in the syntax. The
online databases PubMed/MEDLINE, SCOPUS, EMBASE, ISI
Web of Science were considered, as well as the gray literature
and a manual search from the references of the articles
retrieved.
Original articles published between 2000 and 2014 were
retrieved, with restriction criteria applied to the European
region and to the English language. Qualitative and quantitative
studies describing the determinants underlying vaccination
uptake in parents were included in the review. Studies were
required to focus on routine childhood vaccinations against
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MMR. Information was collected from parents’ answers both to
questions speciﬁc on MMR vaccine and questions regarding all
the vaccine schedule including the MMR vaccine.
The following exclusion criteria were initially applied:
articles published in a language different from the English
idiom, including non-European countries or rural areas only,
reporting vaccination information on sick populations, very
pre-term infants and migrants; as well as assessing only the
impact or the coverage of vaccination, reporting uptake deter-
minants not on parents (e.g., general practitioners, university
students, workers, etc). Focus groups with less than 10 parents
were arbitrarily excluded from the full text analysis, and other
exclusion criteria were applied such as not reporting direct
linking with uptake (e.g. linking with adverse publicity or with
information-seeking), methodology studies or papers reporting
no speciﬁc indications on MMR. Studies were then selected for
the qualitative and quantitative analysis.
Variables extraction was conducted on the basis of previ-
ously identiﬁed potential classes of determinants, adapted from
previous SLR.4,50 These classes included: knowledge, beliefs and
perceptions both on vaccines and diseases (KBPvd); attitudes/
behaviors; demographics, including ethnicity, mother’s age,
child’ age, gender, geographic location; socio-economic status
(SES), including education level, employment, house tenure,
income, marital status, no. of children in the household; infor-
mation source/advice; inﬂuence/trust of other people, institu-
tions, media; practical reasons. The literature search and the
systematic review were conducted by 2 independent investiga-
tors, that, in case of any incongruity, came up to an agreement
after further discussion.
Meta-analysis
After selecting the articles reporting Odds Ratios (ORs) and
95% Conﬁdence Intervals (CIs) as measures of association of
the underlying determinants with the vaccine uptake, a meta-
analysis was conducted on the extracted measures in order to
assess the overall effect. The dependent variable was the “vac-
cine uptake” and the considered determinants were the inde-
pendent variables. When the outcome variable of the examined
study was the non-uptake, the inverse of the ORs were calcu-
lated and included in the analysis. Adjusted ORs were consid-
ered where available, with unadjusted ORs used if not reported,
and the logarithms were used for the meta-analysis, with expo-
nentiated effect sizes and conﬁdence intervals displayed in the
forest plots.
Pooled estimates were calculated using both ﬁxed effects and
DerSimonian and Laird 56 random effects models, weighting
individual study results by the inverse of their variances. Forest
plots were used to visually assess the pooled estimates and cor-
responding 95% CI across studies. A test of heterogeneity was
performed using a chi-square test57 at signiﬁcance level of
p < 0.05 and reported with the I2 statistic, in which cut-offs of
25%, 50% and 75% indicated low, moderate and high heteroge-
neity, respectively.58
When the test showed signiﬁcant heterogeneity, the sources
of heterogeneity were explored through subgroup and sensitiv-
ity analyses. The following variables were considered for the
subgroup analysis: questionnaires reporting on MMR vaccine
alone MMR plus other vaccines included in the local schedule,
MMR vaccine schedule adherence (all recommended doses, 1
dose, both), geographical location (Northern, Western, South-
ern Europe), children’s age at the moment of the study (<5 y,
>5 y, mixed age), data collection method (interview, question-
naire, ofﬁcial database), administration modality (interviewer-
administered face-to-face, interviewer-administered telephone,
self-administered postal, self-administered hand, records),
administration setting (home, hospital/nursery/primary care
trust, day-care centers/schools, other). When more than 1
modality was present, variables were dichotomized for the sake
of analysis. Sensitivity analyses were conducted to examine the
contribution of each individual study by evaluating the impact
of the outlier studies, eliminating each study from the meta-
analysis and comparing the point estimates including and
excluding the study.
To assess the potential of publication bias, a graphical plot of
estimates of the logarithm of the effect versus its standard error
for each study was employed and the Egger test was per-
formed.59,60 To overcome the limit of the Egger test due to the
presence of small studies, evidence of asymmetry has been set
on p < 0.1 and intercepts have been presented with 90% CI.60
In order to aid visual interpretation, contour lines were
included corresponding to perceived milestones of statistical
signiﬁcance (P D 0.01, 0.05, 0.1, etc.).61,62 Results were also dis-
played in a Galbraith plot, where the standard normal deviate
of intervention effect estimate is plotted against its precision.
The methodological quality of quantitative studies included
in the meta-analysis was assessed using revised versions of pre-
viously validated checklists for quantitative cross-sectional and
retrospective studies62 as recommended by the Cochrane
Collaboration.63
All data were analyzed by using the statistical package of
STATA/MP 12.1 (StataCorp LP, College Station, TX, USA),
with the “metan” command used for meta-analysis “metafun-
nel,” “metabias” and “confunnel” for publication bias
assessment.64
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